Impact of Relative Dose Intensity of Docetaxel, Cisplatin, and 5-Fluorouracil Neoadjuvant Chemotherapy on Survival of Esophageal Squamous Cell Cancer Patients.

Osamu ShiraishiHiroaki KatoKota MomoseYoko HirakiAtsushi YasudaMasayuki ShinkaiMotohiro ImanoTakushi Yasuda

Published in: Oncology (2023)

An average RDI of more than or equal to 80% improved prognosis in patients receiving DCF-NAC for ESCC.

Keyphrases